Jun Watanabe

Niigata, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications

The dual role of Schlafen11 in brain tumors: Jekyll and Hyde.

The dual role of Schlafen11 in brain tumors: Jekyll and Hyde.

Journal: Expert review of anticancer therapy
Published: June 24, 2026

Treatment initiation by positive liquid biopsy alone in primary central nervous system lymphoma: A retrospective analysis of a multi-institutional study.

Treatment initiation by positive liquid biopsy alone in primary central nervous system lymphoma: A retrospective analysis of a multi-institutional study.

Journal: Neuro-oncology advances
Published: July 20, 2025

Effects of combination therapy of a CDK4/6 and MEK inhibitor in diffuse midline glioma preclinical models.

Effects of combination therapy of a CDK4/6 and MEK inhibitor in diffuse midline glioma preclinical models.

Journal: PloS one
Published: April 11, 2025

Near-Infrared Photoimmunotherapy in Brain Tumors-An Unexplored Frontier.

Near-Infrared Photoimmunotherapy in Brain Tumors-An Unexplored Frontier.

Journal: Pharmaceuticals (Basel, Switzerland)
Published: March 31, 2025

Diagnosis of Leptomeningeal Disease in Diffuse Midline Gliomas by Detection of H3F3A K27M Mutation in Circulating Tumor DNA of Cerebrospinal Fluid.

Diagnosis of Leptomeningeal Disease in Diffuse Midline Gliomas by Detection of H3F3A K27M Mutation in Circulating Tumor DNA of Cerebrospinal Fluid.

Journal: Pediatric blood & cancer
Published: October 04, 2024

Recent advances in liquid biopsy of central nervous system lymphomas: case presentations and review of the literature.

Recent advances in liquid biopsy of central nervous system lymphomas: case presentations and review of the literature.

Journal: Brain tumor pathology
Published: February 18, 2024

Reliable detection of genetic alterations in cyst fluid DNA for the diagnosis of brain tumors.

Reliable detection of genetic alterations in cyst fluid DNA for the diagnosis of brain tumors.

Journal: Journal of neuro-oncology
Published: November 10, 2023

BET bromodomain inhibition potentiates radiosensitivity in models of H3K27-altered diffuse midline glioma.

BET bromodomain inhibition potentiates radiosensitivity in models of H3K27-altered diffuse midline glioma.

Journal: The Journal of clinical investigation
Published: August 17, 2023

Administration of glucocorticoids prior to liquid biopsy dramatically reduces the detection rate of MYD88 L265P mutation in cerebrospinal fluid of primary CNS lymphoma patients.

Administration of glucocorticoids prior to liquid biopsy dramatically reduces the detection rate of MYD88 L265P mutation in cerebrospinal fluid of primary CNS lymphoma patients.

Journal: Leukemia & lymphoma
Published: April 18, 2023

CHD2 Regulates Neuron-Glioma Interactions in Pediatric Glioma.

CHD2 Regulates Neuron-Glioma Interactions in Pediatric Glioma.

Journal: Cancer discovery
Published: January 04, 2023

Epigenetic upregulation of Schlafen11 renders 
WNT- and SHH-activated medulloblastomas sensitive to cisplatin.

Epigenetic upregulation of Schlafen11 renders 
WNT- and SHH-activated medulloblastomas sensitive to cisplatin.

Journal: Neuro-oncology
Published: October 23, 2022

POU2AF2/C11orf53 functions as a coactivator of POU2F3 by maintaining chromatin accessibility and enhancer activity.

POU2AF2/C11orf53 functions as a coactivator of POU2F3 by maintaining chromatin accessibility and enhancer activity.

Journal: Science advances
Published: October 05, 2022
Showing 1-12 of 33

Last Updated: 09/26/2026